Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Slide

Innovations Inspired
by life

About Sparc

About Us

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics to improve standards of care for patients worldwide. At SPARC, our therapeutic focus is in the area of oncology and immunology two critical fields that pose significant challenges in healthcare.

Read More

Therapeutic Focus

Oncology

We pioneer precision medicines and targeted delivery to overcome treatment resistance and achieve lasting remission.

Neurodegeneration

We explore new pathways to address the root causes of neurodegeneration, altering disease progression and enhancing patients' quality of life.

R&D Pipeline

Asset / Program

MoA

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Oncology

Vodobatinib
(SCO-088)

BCR-ABL
Inhibitor

Refractory CML

SBO-154

Anti-MUC-1 ADC

Multiple Tumors

Immunology

Vibozilimod
(SCD-044)

Selective
S1PR1 Agonist

Psoriasis
Atopic Dermatitis

SCD-153

Undisclosed

Alopecia Areata

R&D Pipeline

Vodobatinib (SCO-088)

Phase 2

BCR-ABL Inhibitor for Refractory CML

SBO-154

Preclinical

Anti-MUC-1 ADC for Multiple Tumors

Vibozilimod (SCD-044)

Phase 2

Selective S1PR1 Agonist for Psoriasis

Vibozilimod (SCD-044)

Phase 2

Selective S1PR1 Agonist for Atopic Dermatitis

SCD-153

Phase 1

Undisclosed for Alopecia Areata
  • Oncology
  • Immunology
Copyright @ 2024. All Rights Reserved.
Follow Us :
Linkedin